1. Home
  2. Press release
Oct 01, 2019 11:46 JST

Source: Eisai

Eisai: Final Study Results Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Treatment in Advanced Endometrial Cancer Presented at ESMO 2019 Congress

TOKYO, Oct 01, 2019 - (JCN Newswire) - Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (NYSE: MRK), known as MSD outside the United States and Canada, announced final results from the full endometrial cancer cohort of KEYNOTE- 146/Study 111 evaluating LENVIMA, an orally available kinase inhibitor discovered by Eisai , plus KEYTRUDA, Merck & Co., Inc., Kenilworth, N.J., U.S.A.'s anti-PD-1 therapy. The findings were presented in a proffered paper presentation at the European Society for Medical Oncology (ESMO) 2019 Congress (Abstract #994O).

For the full report, visit https://www.eisai.com/news/2019/pdf/enews201977pdf.pdf.

Contact:
Eisai Co., Ltd. 
Media Relations 
+81-(0)3-3817-5120

Merck & Co., Inc., Kenilworth, N.J., U.S.A. 
Media Relations 
Pamela Eisele: (267) 305-3558 
Kristen Drake: (908) 334-4688
Source: Eisai
Sectors: BioTech

Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release

Eisai to Showcase Alzheimer's Disease Portfolio with More Than 50 Presentations at the Alzheimer's Association International Conference(R) 2026 (AAIC(R))
July 02 2026 21:45 JST
 
UCL and Eisai renew partnership to accelerate treatments for neurodegenerative diseases
July 02 2026 21:01 JST
 
Eisai Announces Strategic Investment Supported by the UK Government's LSIMF
June 17 2026 12:28 JST
 
Eisai Deepens Body of Clinical Evidence for LENVIMA(R) (Lenvatinib) Across Established Indications at ASCO 2026
May 21 2026 23:23 JST
 
Merck & Co., Inc., Rahway, NJ, USA and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
April 21 2026 19:52 JST
 
Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy
March 27 2026 19:14 JST
 
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
March 27 2026 17:19 JST
 
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026
March 23 2026 10:19 JST
 
Eisai: Regarding Discontinuation of Administration of "Tazverik(R) Tablets 200mg" (tazemetostat hydrobromide)
March 19 2026 09:54 JST
 
Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation
March 17 2026 18:49 JST
 
More Press release >>

Latest Press Release


MHI Receives Order from Taiwan High Speed Rail Corporation for Maintenance Tools and Equipment for Yanchao Main Workshop
Jul 03, 2026 00:22 JST

Hitachi Rail completes acquisition of Clever Devices, expanding its portfolio of multi-modal transport solutions

Jul 02, 2026 23:15 JST

Eisai to Showcase Alzheimer's Disease Portfolio with More Than 50 Presentations at the Alzheimer's Association International Conference(R) 2026 (AAIC(R))
Jul 02, 2026 22:45 JST

UCL and Eisai renew partnership to accelerate treatments for neurodegenerative diseases
Jul 02, 2026 22:01 JST

Fujitsu Group achieves gold medal in EcoVadis sustainability rating
Jul 02, 2026 15:00 JST

NEC drives digital transformation at Messer Gases in Brazil with Cisco advanced networking and security solutions
Jul 02, 2026 15:00 JST

JCB Contactless Payment Now Available on Taipei Metro
Jul 01, 2026 10:00 JST

Hitachi High-Tech opens Innovation Center Eindhoven in the Netherlands to accelerate open innovation
Jul 01, 2026 00:59 JST

Honda to Commemorate 40th Anniversary of Its First F1(TM) Title
Jul 01, 2026 00:48 JST

Honda Issues "Honda ESG Report 2026"
Jul 01, 2026 00:24 JST

Sharp Signs Memorandum of Understanding with Major Global Satellite Operator SES to Build a Collaboration in Satellite Communication Services
Jul 01, 2026 00:09 JST

Mitsubishi Motors to Bring Authentic Off-Road Performance to Life with its All-New Pajero Cross-Country SUV
Jun 30, 2026 23:46 JST

MHIEC Completes Rebuild of Nagasaki City East Plant
Jun 30, 2026 23:04 JST

NEC Recognized as a Specialist in Gartner(R) Emerging Market Quadrant for Physical AI Services - Established Vendors
Jun 30, 2026 22:47 JST

DENSO and TUV Rheinland Japan Confirm the Practicality of Battery Passport for AESC's Energy Storage Product Using Actual Data
Jun 30, 2026 22:10 JST

Mitsubishi Shipbuilding Receives Order for the MAmmoSS(R) Ammonia Fuel Handling System
Jun 27, 2026 13:16 JST

MHI Study Results Indicate Potential Cost Reductions in the Decarbonization Value Chain Using Green Hydrogen and Ammonia Produced in India
Jun 27, 2026 13:00 JST

Foxconn and Sharp Signs Memorandum of Understanding for Strategic Collaboration in New Business Areas
Jun 27, 2026 12:44 JST

DENSO Group Formulates New Environmental Policy "Eco Vision 2035"
Jun 27, 2026 11:58 JST

JCB and PNB Launch New Platinum Credit Card, Empowering Consumers with Greater Value and Lifestyle Benefits
Jun 26, 2026 19:00 JST
 More Latest Release >>